Artificial Intelligence▲ bullishImpact 8/10
Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials
The Decoder·
✦AI Analysis
Isomorphic Labs, an AI drug research firm co-founded by Demis Hassabis, has secured $2.1 billion in a Series B funding round led by Thrive Capital. The investment will be used to enhance its IsoDDE platform and push drug candidates towards clinical trials.
Key Topics
Isomorphic LabsDeepMindThrive CapitalIsoDDE
Originally reported by The Decoder. Read the full article ↗